Impel Pharmaceuticals Ownership 2024 | Who Owns Impel Pharmaceuticals Now?


OverviewRevenueFinancialsChart

Institutional Ownership

11.63%

Insider Ownership

0.52%

Retail Ownership

87.85%

Institutional Holders

2.00

Impel Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ST GERMAIN D J CO INC----1,500-100.00%-Mar 31, 2024
VENBIO PARTNERS LLC----2,759,791-100.00%-Mar 31, 2024

Impel Pharmaceuticals's largest institutional shareholder is ST GERMAIN D J CO INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ST GERMAIN D J CO INC----1,500-100.00%-Mar 31, 2024
VENBIO PARTNERS LLC----2,759,791-100.00%-Mar 31, 2024

The largest Impel Pharmaceuticals shareholder by % of total assets is ST GERMAIN D J CO INC. The company owns 0.00 shares of Impel Pharmaceuticals (IMPL), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ST GERMAIN D J CO INC----1,500-100.00%-Mar 31, 2024
VENBIO PARTNERS LLC----2,759,791-100.00%-Mar 31, 2024

As of Mar 31 2024, Impel Pharmaceuticals's largest institutional buyer is ST GERMAIN D J CO INC. The company purchased -1.50K stocks of IMPL, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VENBIO PARTNERS LLC----2,759,791-100.00%-Mar 31, 2024
ST GERMAIN D J CO INC----1,500-100.00%-Mar 31, 2024

As of Mar 31 2024, Impel Pharmaceuticals's biggest institutional seller is VENBIO PARTNERS LLC. The company sold -2.76M shares of IMPL, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VENBIO PARTNERS LLC----2,759,791-100.00%-Mar 31, 2024
ST GERMAIN D J CO INC----1,500-100.00%-Mar 31, 2024

Impel Pharmaceuticals's largest sold out institutional shareholder by shares sold is VENBIO PARTNERS LLC, sold -2.76M shares, valued at -, as of undefined.

Impel Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY COMMONWEALTH TRUST0.03%87,484--Feb 29, 2024
BRIDGEWAY FUNDS INC0.02%60,000--Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS0.01%6,194--Dec 31, 2023
VICTORY PORTFOLIOS0.00%61,460--Dec 31, 2023
ALPS ETF Trust0.00%22,298--Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%723--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.00%10,369--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%492,946--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%95,834--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%12,285--Dec 31, 2023
RUSSELL INVESTMENT CO0.00%114,031--Jan 31, 2024
RUSSELL INVESTMENT FUNDS0.00%19,247--Dec 31, 2023
Principal Exchange-Traded Funds0.00%2,210--Mar 31, 2024
Calvert Variable Products, Inc.0.00%422--Dec 31, 2023
SCHWAB CAPITAL TRUST0.00%6,722--Feb 29, 2024
FIDELITY SALEM STREET TRUST0.00%48,043--Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%1,500--Dec 31, 2023
ProFunds0.00%138--Jan 31, 2024
RYDEX SERIES FUNDS0.00%49--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%20,914--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%146--Feb 29, 2024
VALIC Co I0.00%2,373--Feb 29, 2024
PROSHARES TRUST0.00%1,997--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%30--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%358--Feb 29, 2024
Guggenheim Active Allocation Fund0.00%33--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%717--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%6--Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%682--Dec 31, 2023
NORTHERN FUNDS0.00%3,917--Dec 29, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%339--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%6,200--Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%706--Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%1,889--Dec 31, 2023
BLACKROCK FUNDS0.00%8,163--Feb 29, 2024
iSHARES TRUST0.00%17,882--Feb 29, 2024
EQ ADVISORS TRUST0.00%1,076--Dec 31, 2023
PACIFIC SELECT FUND0.00%2,356--Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%2,621--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%508--Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%519--Dec 31, 2023
Bridge Builder Trust0.00%1,007--Dec 31, 2023
PRINCIPAL FUNDS, INC.0.00%826--Feb 29, 2024

Impel Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 87.48K shares, compromising 0.03% of its total assets.

Impel Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 232-93.55%
30 Sep, 2331-
30 Jun, 2331-3.13%
31 Mar, 2332-8.57%
31 Dec, 22352.94%
30 Sep, 22346.25%
30 Jun, 2232-23.81%
31 Mar, 2242-4.55%
31 Dec, 2144-
30 Sep, 214433.33%
30 Jun, 2133-

As of 31 Dec 23, 2 institutions are holding Impel Pharmaceuticals's shares, representing a decrease of -93.55% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 232,761,291-83.85%
30 Sep, 2317,095,707-2.54%
30 Jun, 2317,540,983-0.84%
31 Mar, 2317,688,775-1.23%
31 Dec, 2217,909,44618.07%
30 Sep, 2215,168,5170.55%
30 Jun, 2215,085,0490.43%
31 Mar, 2215,020,941-1.64%
31 Dec, 2115,271,843-16.39%
30 Sep, 2118,266,2927.97%
30 Jun, 2116,918,302-

Impel Pharmaceuticals (IMPL) has 2.76M shares outstanding as of 31 Dec 23, down -83.85% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 2311.63%0.22%
30 Sep, 2371.99%1.32%
30 Jun, 2373.87%1.33%
31 Mar, 2374.49%1.31%
31 Dec, 2275.44%1.84%
30 Sep, 2263.98%1.51%
30 Jun, 2265.08%1.55%
31 Mar, 2264.90%1.48%
31 Dec, 2166.20%0.81%
30 Sep, 2190.65%0.63%
30 Jun, 21119.82%-

As of 31 Dec 23, Impel Pharmaceuticals is held by 11.63% institutional shareholders, representing a 0.22% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 23--100.00%
30 Sep, 23980.00%
30 Jun, 235-44.44%
31 Mar, 239-30.77%
31 Dec, 2213-
30 Sep, 221330.00%
30 Jun, 2210-44.44%
31 Mar, 2218-40.00%
31 Dec, 21307.14%
30 Sep, 2128-15.15%
30 Jun, 2133-

- institutional shareholders have increased their position in IMPL stock as of 31 Dec 23 compared to 9 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23--100.00%
30 Sep, 23620.00%
30 Jun, 235-28.57%
31 Mar, 237-30.00%
31 Dec, 221042.86%
30 Sep, 227-50.00%
30 Jun, 221416.67%
31 Mar, 2212200.00%
31 Dec, 214-55.56%
30 Sep, 219-
30 Jun, 21--

- institutional shareholders have reduced their position in IMPL stock as of 31 Dec 23 compared to 6 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 232-93.55%2,761,291-83.85%11.63%0.22%--100.00%--100.00%
30 Sep, 2331-17,095,707-2.54%71.99%1.32%980.00%620.00%
30 Jun, 2331-3.13%17,540,983-0.84%73.87%1.33%5-44.44%5-28.57%
31 Mar, 2332-8.57%17,688,775-1.23%74.49%1.31%9-30.77%7-30.00%
31 Dec, 22352.94%17,909,44618.07%75.44%1.84%13-1042.86%
30 Sep, 22346.25%15,168,5170.55%63.98%1.51%1330.00%7-50.00%
30 Jun, 2232-23.81%15,085,0490.43%65.08%1.55%10-44.44%1416.67%
31 Mar, 2242-4.55%15,020,941-1.64%64.90%1.48%18-40.00%12200.00%
31 Dec, 2144-15,271,843-16.39%66.20%0.81%307.14%4-55.56%
30 Sep, 214433.33%18,266,2927.97%90.65%0.63%28-15.15%9-
30 Jun, 2133-16,918,302-119.82%-33---

Impel Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell87,934$0.29$25.50K2,447,181
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell209,029$0.11$22.99K2,238,152
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell208,657$0.08$16.69K2,029,495
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell12,066$0.29$3.50K337,608
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell28,682$0.11$3.16K308,926
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell28,632$0.08$2.29K280,294

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell87,934$0.29$25.50K2,447,181
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell209,029$0.11$22.99K2,238,152
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell208,657$0.08$16.69K2,029,495
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell12,066$0.29$3.50K337,608
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell28,682$0.11$3.16K308,926
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell28,632$0.08$2.29K280,294

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 26, 2023Smith Brandon Dofficer-Buy----
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell87,934$0.29$25.50K2,447,181
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell209,029$0.11$22.99K2,238,152
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell208,657$0.08$16.69K2,029,495
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell12,066$0.29$3.50K337,608
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell28,682$0.11$3.16K308,926
Dec 19, 2023Vivo Capital VIII, LLC10 percent owner-S-SaleSell28,632$0.08$2.29K280,294
Dec 04, 2023BROOKFIELD Corp /ON/10 percent owner-J-OtherBuy445,294$0.01$4.45K3,117,057
Dec 04, 2023Oaktree GCP Fund Delaware Holdings, L.P.10 percent owner-J-OtherBuy445,294$0.01$4.45K3,117,057
Dec 04, 2023Oaktree-TCDRS Strategic Credit, LLC10 percent owner-J-OtherBuy445,294$0.01$4.45K3,117,057
Nov 20, 2023BROOKFIELD Corp /ON/10 percent owner-Buy2,671,763$0.01$26.72K-
Nov 20, 2023Oaktree GCP Fund Delaware Holdings, L.P.10 percent owner-Buy2,671,763$0.01$26.72K-
Nov 20, 2023Oaktree-TCDRS Strategic Credit, LLC10 percent owner-Buy2,671,763$0.01$26.72K-
Jun 20, 2023Cline Darren Sdirector-A-AwardBuy13,222$1.34$17.72K13,222
Jun 20, 2023Wilfong Diane E.director-A-AwardBuy13,222$1.34$17.72K13,222
Jun 20, 2023SHAH MAHENDRAdirector-A-AwardBuy13,222$1.34$17.72K13,222
Jun 20, 2023NELSON TIMOTHY Sdirector-A-AwardBuy13,222$1.34$17.72K13,222
Jun 20, 2023Allison David D.director-A-AwardBuy13,222$1.34$17.72K13,222
May 12, 2023Kalb Michael Wayneofficer CFOA-AwardBuy175,000$2.43$425.25K175,000
May 12, 2023Kalb Michael Wayneofficer CFOA-AwardBuy47,500--47,500

The last insider sell of Impel Pharmaceuticals's stock was made by Vivo Capital VIII, LLC on Dec 19 2023, selling 87,934 shares at $0.29 per share (valued at $25.50K).

Impel Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 20233650.00%
Q2 202382400.00%
Q1 20234580.00%
Q4 20221250.00%
Q2 20225--
Q1 20226--
Q4 20214--
Q3 2021163533.33%
Q2 2021407057.14%

3 total buy trades, and 6 total sell trades (buy/sell ratio of 0.50%) were made by Impel Pharmaceuticals's insiders, as of Q4 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2023-6-
Q2 2023---
Q1 2023---
Q4 2022---
Q2 2022---
Q1 2022---
Q4 20211--
Q3 20213--
Q2 20216--

As of Q4 2023, Insider owners conducted 0 open market buy trades and 6 open market sell trades of Impel Pharmaceuticals's stocks.

Impel Pharmaceuticals Peer Ownership


TickerCompany
ANTXAN2 Therapeutics, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
SNTISenti Biosciences, Inc.
PMVPPMV Pharmaceuticals, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
CVKDCadrenal Therapeutics, Inc. Common Stock
FHTXFoghorn Therapeutics Inc.
ENOBRenovaro Biosciences Inc.
CYTCyteir Therapeutics, Inc.
HCWBHCW Biologics Inc.
ELYMEliem Therapeutics, Inc.
ELDNEledon Pharmaceuticals, Inc.
ACXPAcurx Pharmaceuticals, Inc.
PTIXProtagenic Therapeutics, Inc.
CADLCandel Therapeutics, Inc.
MNPRMonopar Therapeutics Inc.
CYTOAltamira Therapeutics Ltd.
ATXIAvenue Therapeutics, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.

IMPL Ownership FAQ


Impel Pharmaceuticals is owned by institutional shareholders (11.63%), insiders (0.52%), and public (87.85%). The largest institutional shareholder of Impel Pharmaceuticals is ST GERMAIN D J CO INC (0% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.03% of total shares).

Impel Pharmaceuticals's major institutional shareholders are ST GERMAIN D J CO INC, and VENBIO PARTNERS LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Dec 2023, there are 2 institutional shareholders of Impel Pharmaceuticals.

ST GERMAIN D J CO INC owns 0 shares of Impel Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

As of Mar 2024, VENBIO PARTNERS LLC holds 0 shares of Impel Pharmaceuticals (IMPL), compromising 0% of the company, valued at $0.